ArthroCare to split stock in two-for-one deal:
This article was originally published in Clinica
Executive Summary
ArthroCare, which markets devices based on its proprietary coblation technology, is to split its shares in a two-for-one deal, subject to shareholder approval. The Sunnyvale, California-based company has developed its radiofrequency ablation technology for a number of soft tissue surgery applications.